Atlas Trials

Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis

Clinical trial NCT01826201 · COMPLETED

Trial details

NCT number
NCT01826201
Sponsor
Moleculin, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Psoriasis
Start date
2013-03-01
Primary completion
2013-08-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.